


Stort reportage i Sydsvenskan
Stort reportage om Iconovo i Sydsvenskan
Sydsvenskan som är Södra Sveriges ledande morgontidning, ägnar två helsidor åt Lundabolaget…


Improved performance with inhalation
When you think of inhaled medicine, you often think of treatments for asthma, COPD and other conditions in the lungs and airways. Today,…

Replacing injections with inhalation
There are many therapies given as injections, that are temperature sensitive and challenging to store and transport, for example insulin…

Inhalation made easy with ICOone
There is a growing interest in delivering drugs by inhalation, not only medicines that treat the lungs and airways – such as those against…


Johan Wäborg presenterar Iconovo på Aktiedagen
Iconovo utvecklar och förnyar inhalation av läkemedel och vaccin
Iconovo utvecklar och förnyar inhalation av läkemedel och vaccin. Många…




Invitation to companies in Japan
In July, Måns Österberg, Director Alliance Management will visit our collaboration partners in Japan to develop the projects further. There will also…
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
ICONOVO AB
VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B
POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 70 LUND
Sweden
CONTACT
Phone: +46 46 275 67 77
VP Business Development
Roger Lassing
Mail: roger.lassing@iconovo.se
CEO
Johan Wäborg
Mail: johan.waborg@iconovo.se